News

The global Binder Excipients market, valued at US$2.0 Billion in 2024, is set to reach US$2.7 Billion by 2030 with a CAGR of 5.3%. Key drivers includ ...
However, like other aspects of drug development, it is evolving ... through concepts including stakeholder engagement, Quality by Design (QbD), and Critical to Quality (CtQ) factors.